PLEKHA8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.01849999942527E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.35249999997112E-06 |
Normal-vs-Stage2 |
5.219800E-02 |
Normal-vs-Stage3 |
9.57299994830407E-09 |
Normal-vs-Stage4 |
7.08960000039838E-07 |
Stage1-vs-Stage2 |
4.550400E-01 |
Stage1-vs-Stage3 |
1.966030E-02 |
Stage1-vs-Stage4 |
1.165990E-01 |
Stage2-vs-Stage3 |
4.315500E-02 |
Stage2-vs-Stage4 |
9.928400E-02 |
Stage3-vs-Stage4 |
6.898600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.22339999966792E-07 |
Normal-vs-AfricanAmerican |
2.06660000223735E-09 |
Normal-vs-Asian |
5.315900E-02 |
Caucasian-vs-AfricanAmerican |
6.618900E-03 |
Caucasian-vs-Asian |
9.685600E-01 |
AfricanAmerican-vs-Asian |
3.078200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.24410000032793E-07 |
Normal-vs-Female |
5.37450000059891E-08 |
Male-vs-Female |
3.658200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.421800E-03 |
Normal-vs-Age(41-60Yrs) |
7.33070000036307E-07 |
Normal-vs-Age(61-80Yrs) |
1.25719999966023E-07 |
Normal-vs-Age(81-100Yrs) |
9.462100E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.077800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.783800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.131800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.980000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.457600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.313400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.482300E-02 |
Normal-vs-Grade 2 |
1.56539999995875E-06 |
Normal-vs-Grade 3 |
1.85260000007403E-07 |
Normal-vs-Grade 4 |
2.49780000000088E-05 |
Grade 1-vs-Grade 2 |
6.275200E-01 |
Grade 1-vs-Grade 3 |
4.731800E-01 |
Grade 1-vs-Grade 4 |
3.906800E-01 |
Grade 2-vs-Grade 3 |
4.901600E-01 |
Grade 2-vs-Grade 4 |
2.867800E-01 |
Grade 3-vs-Grade 4 |
5.711400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.368900E-04 |
Normal-vs-ccB subtype |
3.18150000000461E-06 |
ccA subtype-vs-ccB subtype |
1.056240E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.89379999974093E-07 |
Normal-vs-N1 |
9.817600E-04 |
N0-vs-N1 |
4.323600E-01 |
|
|